STOCK TITAN

iRobot Corporation (IRBT) Financials

IRBT
Trailing 12 months to September 27, 2025
Revenue $547.0M -33.1% YoY
Net Income -$208.7M -58.1% YoY
EPS (Diluted) -$6.72 -46.1% YoY
Free Cash Flow -$106.9M -234.0% YoY
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2025, ended Sep 27, 2025 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2025, filed Nov 6, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the IRBT SEC filings page.

iRobot Corporation (IRBT) reported $547.0M in revenue over the twelve months to Sep 27, 2025, down 33.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI IRBT FY2024

iRobot’s dominant mechanic is contraction with cost pullback: revenue and gross margin fell while cash losses narrowed and leverage intensified.

FY2024 revenue was $681.8M and gross margin was 20.9%, both below FY2023 levels; the commercial base weakened even as reported operating loss narrowed. Operating cash flow improved from -$114.8M to -$33.2M as R&D and capital spending were reduced, indicating cash preservation through retrenchment rather than improved demand economics.

Balance-sheet contraction is now the more consequential story: FY2024 assets were $516.1M against $454.9M of liabilities, leaving a much thinner equity buffer. Debt-to-equity reached 7.4x as equity fell to $61.2M, so the ratio’s jump reflects balance-sheet pressure and a depleted denominator.

Reported liquidity equals 48.5 months of latest annual operating outflow, a balance-to-past-outflow comparison rather than a forecast; that cushion coexists with FY2024 free cash flow of -$33.3M, so liquidity and earnings quality should be read separately. With capital expenditures at just $118K, the cash deficit was not driven by heavy reinvestment in the period.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 16 / 100
Financial Health Score 16/100

Scored against operating companies for FY2024. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of iRobot Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
22

iRobot Corporation has an operating margin of -15.1%, meaning the company loses $15 on every $100 of revenue. This results in a profitability score of 22/100. This is up from -29.6% the prior year.

Growth
3

iRobot Corporation's revenue declined 23.4% year-over-year, from $890.6M to $681.8M. This contraction results in a growth score of 3/100.

Leverage
7

iRobot Corporation has elevated debt relative to equity (D/E of 7.43), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 7/100, reflecting increased financial risk.

Liquidity
34

iRobot Corporation's current ratio of 1.32 indicates adequate short-term liquidity, earning a score of 34/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
13

iRobot Corporation's operations used $33.2M of cash, and capex of $118K added to the outflow, for a free cash flow shortfall of $33.3M. This results in a cash flow score of 13/100.

Returns
18

iRobot Corporation posts a -237.6% return on equity (ROE), meaning it loses $238 for every $100 of shareholders' equity. This results in a returns score of 18/100. This is down from -155.1% the prior year.

Altman Z-Score Distress
0.30

iRobot Corporation scores 0.30, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($113.9M) relative to total liabilities ($454.9M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
3/8

iRobot Corporation passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing
N/A

iRobot Corporation reported a net loss of $145.5M while operations used $33.2M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

iRobot Corporation reported an operating loss of $103.0M against $21.5M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$145.8M
YoY-24.6%
QoQ+14.3%
5Y CAGR-5.4%
10Y CAGR+0.2%

iRobot Corporation generated $145.8M in revenue in Q3 2025. This represents a decrease of 24.6% from the same quarter a year earlier. Against the prior quarter it is up 14.3%.

EBITDA
-$16.1M
YoY-223.6%
QoQ+53.8%

iRobot Corporation's EBITDA was -$16.1M in Q3 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 223.6% from the same quarter a year earlier. Against the prior quarter it is up 53.8%.

Net Income
-$21.5M
YoY-237.9%
QoQ+5.6%

iRobot Corporation reported -$21.5M in net income in Q3 2025. This represents a decrease of 237.9% from the same quarter a year earlier. Against the prior quarter it is up 5.6%.

EPS (Diluted)
-$0.62
YoY-195.2%
QoQ+8.8%

iRobot Corporation earned -$0.62 per diluted share (EPS) in Q3 2025. This represents a decrease of 195.2% from the same quarter a year earlier. Against the prior quarter it is up 8.8%.

Cash & Balance Sheet

Free Cash Flow
-$47.6M
YoY-364.6%
QoQ-57.8%

iRobot Corporation recorded an outflow of $47.6M in free cash flow in Q3 2025, representing a cash shortfall after capex. This represents a decrease of 364.6% from the same quarter a year earlier. Against the prior quarter it is down 57.8%.

Cash & Debt
$24.8M
YoY-75.0%
QoQ-38.8%
5Y CAGR-36.9%
10Y CAGR-16.4%

iRobot Corporation held $24.8M in cash as of Q3 2025; long-term debt is not reported for that period.

Shares Outstanding
32M
YoY+4.1%
QoQ+1.5%
5Y CAGR+2.7%
10Y CAGR+0.7%

iRobot Corporation had 32M shares outstanding in Q3 2025. This represents an increase of 4.1% from the same quarter a year earlier. Against the prior quarter it is up 1.5%.

Dividends Per Share

Not reported for Q3 2025.

Margins & Returns

Gross Margin
31.0%
YoY-1.2pp
QoQ+1.0pp
5Y change-9.5pp
10Y change-16.3pp

iRobot Corporation's gross margin was 31.0% in Q3 2025, indicating the percentage of revenue retained after direct costs. This is down 1.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.0 percentage points.

Operating Margin
-12.1%
YoY-15.9pp
QoQ+16.7pp

iRobot Corporation's operating margin was -12.1% in Q3 2025, reflecting core business profitability. This is down 15.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 16.7 percentage points.

Net Margin
-14.8%
YoY-11.5pp
QoQ+3.1pp
5Y change-5.3pp
10Y change-24.9pp

iRobot Corporation's net profit margin was -14.8% in Q3 2025, showing the share of revenue converted to profit. This is down 11.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.1 percentage points.

Return on Equity

Not reported for Q3 2025.

Capital Allocation

R&D Spending
$13.1M
YoY-33.3%
QoQ-4.9%

iRobot Corporation invested $13.1M in research and development in Q3 2025. This represents a decrease of 33.3% from the same quarter a year earlier. Against the prior quarter it is down 4.9%.

Capital Expenditures
$0

iRobot Corporation reported no capital expenditure in Q3 2025.

Share Buybacks

Not reported for Q3 2025.

IRBT Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IRBT quarterly income statement
MetricQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Revenue$145.8M-24.6%$127.6M-23.3%$101.6M-32.3%$172.0M-44.1%$193.4M+3.9%$166.4M+3.8%$150.0M$307.5M+10.6%
Cost of Revenue$100.6M-23.3%$89.3M-35.7%$81.3M-28.7%$155.6M-37.6%$131.1M-5.2%$138.9M+12.4%$113.9M$249.4M+23.6%
Gross Profit$45.3M-27.5%$38.3M+39.4%$20.3M-43.7%$16.4M-71.8%$62.4M+30.0%$27.5M-25.2%$36.1M$58.1M-23.9%
R&D Expenses$13.1M-33.3%$13.8M-40.7%$14.7M-56.7%$16.5M-38.6%$19.6M-47.4%$23.2M-43.7%$33.9M$26.9M-34.9%
SG&A ExpensesN/AN/AN/AN/AN/AN/AN/A$18.9M-40.0%
Operating Income-$17.7M-343.5%-$36.7M+39.9%-$45.8M-484.5%-$61.0M-16.9%$7.3M+112.2%-$61.1M+24.9%$11.9M-$52.2M+23.6%
EBITDA-$16.1M-223.6%-$35.0M+37.3%-$43.1M-343.5%-$56.3M-37.9%$13.1M+124.6%-$55.8M+24.4%$17.7M-$40.8M+16.7%
Interest Expense$1.6M-70.4%$5.1M-5.6%$5.0M-9.1%$5.2M$5.4M$5.4M$5.5MN/A
Income Tax$3.1M+191.1%-$523K-171.7%$457K+323.1%-$1.5M-123.3%$1.1M+80.6%$729K+157.8%$108K$6.6M-88.8%
Net Income-$21.5M-237.9%-$22.8M+67.7%-$87.3M-1114.0%-$77.1M-21.3%-$6.4M+92.0%-$70.6M+12.9%$8.6M-$63.6M+50.5%
EPS (Basic)-$0.62-195.2%-$0.68+71.8%-$2.84-1016.1%-$2.58-13.2%-$0.21+92.7%-$2.41+18.3%$0.31-$2.28+51.6%
EPS (Diluted)-$0.62-195.2%-$0.68+71.8%-$2.84-1046.7%-$2.58-13.2%-$0.21+92.7%-$2.41+18.3%$0.30-$2.28+51.6%
Diluted Shares (Avg)35M+14.9%33M+14.0%31M+8.7%N/A30M+9.4%29M+6.7%28MN/A

IRBT Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IRBT quarterly balance sheet
MetricQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Total Assets$481.6M-28.1%$480.3M-18.0%$461.5M-26.3%$516.1M-29.7%$669.9M-19.4%$585.9M-11.8%$626.1M$733.7M-29.3%
Current Assets$248.5M-41.4%$244.8M-28.0%$234.3M-37.0%$288.5M-38.0%$423.8M-23.9%$340.1M-6.6%$371.9M$465.5M-35.9%
Cash & Equivalents$24.8M-75.0%$40.6M-62.6%$69.9M-40.9%$134.3M-27.5%$99.4M-47.6%$108.5M+126.5%$118.4M$185.1M+106.6%
Short-Term Investments$0$0$0$0$0$0$0$0
Inventory$140.9M-5.5%$88.2M-13.0%$69.0M-48.3%$76.0M-50.1%$149.2M-39.0%$101.4M-55.9%$133.3M$152.5M-63.6%
Accounts Receivable$56.8M-43.9%$56.1M-17.7%$30.8M-21.7%$49.9M-37.2%$101.3M+37.9%$68.1M+129.8%$39.3M$79.4M-40.3%
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$182.4M+3.7%$182.4M+7.7%$171.5M+1.1%$167.3M-4.5%$175.9M+5.0%$169.4M-0.1%$169.7M$175.1M+9.8%
Total Liabilities$508.5M-2.2%$488.0M+11.7%$462.3M+9.5%$454.9M-15.3%$519.8M-10.2%$436.9M+62.3%$422.1M$537.2M+12.7%
Current Liabilities$480.9M+64.3%$456.6M+106.0%$427.9M+106.4%$218.2M-24.0%$292.6M-10.1%$221.6M+3.6%$207.4M$287.1M-31.7%
Non-Current Liabilities$27.6M-87.9%$31.4M-85.4%$34.4M-84.0%$236.7M-5.4%$227.1M-10.3%$215.2M+290.0%$214.7M$250.1M+345.7%
Total Equity-$26.9M-117.9%-$7.7M-105.2%-$793K-100.4%$61.2M-68.8%$150.2M-40.6%$149.1M-62.3%$204.1M$196.5M-65.0%
Retained Earnings-$382.4M-120.2%-$360.9M-115.7%-$338.1M-249.7%-$250.8M-138.2%-$173.7M-316.5%-$167.3M-241.4%-$96.7M-$105.3M-137.1%

Not reported in any period shown, so not listed: Long-Term Debt.

IRBT Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IRBT quarterly cash flow statement
MetricQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Operating Cash Flow-$47.6M-364.6%-$30.2M-39.2%-$26.5M-1941.3%-$2.7M-137.5%-$10.2M+81.6%-$21.7M+77.1%$1.4M-$1.2M+95.6%
Depreciation & Amortization$1.5M-73.5%$1.8M-66.8%$2.6M-54.9%$4.8M-58.4%$5.8M-11.2%$5.3M-29.7%$5.8M$11.4M-41.0%
Stock-Based CompensationN/AN/A$5.3M-33.1%N/AN/AN/A$7.9MN/A
Capital Expenditures$0$0$0-100.0%$0-100.0%$0-100.0%$0-100.0%$118K-$270K-93.3%
Free Cash Flow-$47.6M-364.6%-$30.2M-39.2%-$26.5M-2106.1%-$2.7M-92.6%-$10.2M+81.8%-$21.7M+77.4%$1.3M-$1.4M+95.3%
Investing Cash Flow$594K+6040.0%-$6K+87.0%-$8K+93.2%-$80K-132.0%-$10K+98.5%-$46K+97.0%-$118K$250K+106.7%
Financing Cash Flow-$114K-108.5%-$4.2M-134.8%-$84K+99.7%-$132K+85.0%$1.3M-99.3%$12.0M-52.8%-$29.9M-$878K-101.6%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

IRBT Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IRBT quarterly financial ratios
MetricQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Gross Margin31.0%-1.2pp30.0%+13.5pp20.0%-4.1pp9.5%-9.4pp32.3%+6.5pp16.5%-6.4pp24.1%18.9%-8.6pp
Operating Margin-12.1%-15.9pp-28.8%+7.9pp-45.0%-53.0pp-35.5%-18.5pp3.8%+35.7pp-36.7%+14.0pp7.9%-17.0%+7.6pp
Net Margin-14.8%-11.5pp-17.9%+24.6pp-85.9%-91.7pp-44.8%-24.1pp-3.3%+39.3pp-42.5%+8.1pp5.7%-20.7%+25.5pp
Return on EquityN/AN/AN/A-125.9%-93.5pp-4.2%+27.1pp-47.4%-26.9pp4.2%-32.4%-9.5pp
Return on Assets-4.5%-3.5pp-4.8%+7.3pp-18.9%-20.3pp-14.9%-6.3pp-0.9%+8.6pp-12.1%+0.1pp1.4%-8.7%+3.7pp
Current Ratio0.52-0.9x0.54-1.0x0.55-1.2x1.32-0.3x1.45-0.3x1.53-0.2x1.791.62-0.1x
Debt-to-EquityN/AN/AN/A7.43+4.7x3.46+1.2x2.93+2.2x2.072.73+1.9x
Asset Turnover0.300.0x0.270.0x0.220.0x0.33-0.1x0.29+0.1x0.280.0x0.240.42+0.2x
FCF Margin-32.6%-27.3pp-23.6%-10.6pp-26.1%-26.9pp-1.6%-1.1pp-5.3%+24.9pp-13.0%+46.8pp0.9%-0.5%+10.4pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
iRobot Corporation IRBT FY2024 $681.8M -$145.5M -21.3% $113.9M 16/100
Purple Innovation, Inc. PRPL FY2025 $468.7M -$51.4M -11.0% $10.3M 22/100
Hooker Furnishings Corporation HOFT FY2026 $278.1M -$27.0M -9.7% $139.6M 43/100
Nova Lifestyle, Inc. NVFY FY2025 $16.7M -$3.4M -20.4% $202.1M 25/100
Virco Mfg. Corporation VIRC FY2026 $199.7M $2.6M 1.3% $98.8M 55/100
Kewaunee Scientific Corp KEQU FY2026 $282.0M $9.6M 3.4% $104.6M 64/100

Frequently Asked Questions

What is iRobot Corporation's annual revenue?

iRobot Corporation (IRBT) reported $681.8M in total revenue for fiscal year 2024. This represents a -23.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is iRobot Corporation's revenue growing?

iRobot Corporation (IRBT) revenue declined by 23.4% year-over-year, from $890.6M to $681.8M in fiscal year 2024.

Is iRobot Corporation profitable?

No, iRobot Corporation (IRBT) reported a net income of -$145.5M in fiscal year 2024, with a net profit margin of -21.3%.

iRobot Corporation (IRBT) reported diluted earnings per share of -$4.92 for fiscal year 2024. This represents a 55.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

iRobot Corporation (IRBT) had EBITDA of -$81.3M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

iRobot Corporation (IRBT) had a gross margin of 20.9% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

iRobot Corporation (IRBT) had an operating margin of -15.1% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

iRobot Corporation (IRBT) had a net profit margin of -21.3% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

iRobot Corporation (IRBT) has a return on equity of -237.6% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

iRobot Corporation (IRBT) recorded an outflow of $33.3M in free cash flow during fiscal year 2024. This represents a 71.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

iRobot Corporation (IRBT) recorded an outflow of $33.2M in operating cash flow during fiscal year 2024, representing cash used by core business activities.

iRobot Corporation (IRBT) had $516.1M in total assets as of fiscal year 2024, including both current and long-term assets.

iRobot Corporation (IRBT) invested $118K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

iRobot Corporation (IRBT) invested $93.3M in research and development during fiscal year 2024.

iRobot Corporation (IRBT) had 31M shares outstanding as of fiscal year 2024.

iRobot Corporation (IRBT) had a current ratio of 1.32 as of fiscal year 2024, which is considered adequate.

iRobot Corporation (IRBT) had a debt-to-equity ratio of 7.43 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

iRobot Corporation (IRBT) had a return on assets of -28.2% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

At the end of fiscal year 2024, iRobot Corporation (IRBT) held $134.3M in cash, cash equivalents and investments, and reported an operating cash outflow of $33.2M over that year. Dividing the one by the other, the reported balance equals about 49 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

iRobot Corporation (IRBT) has an Altman Z-Score of 0.30, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

iRobot Corporation (IRBT) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

iRobot Corporation (IRBT) reported a net loss of $145.5M while operations used $33.2M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

iRobot Corporation (IRBT) reported an operating loss of $103.0M against $21.5M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

iRobot Corporation (IRBT) scores 16 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top